SF3B1突变型骨髓增生异常综合征中克隆进展的不同路径
该研究整合了SF3B1突变MDS患者的临床与分子特征分析,并对原代及诱导多能干细胞来源的人造血干/祖细胞进行基因编辑,发现高危共突变对SF3B1突变型造血干/祖细胞的谱系程序产生不同影响,提示从低危向高危MDS进展依共突变模式涉及不同的分子与细胞路径。
要点
- 继发性RUNX1或STAG2突变在临床上与疾病进展期和生存期缩短相关。
- RUNX1与STAG2突变对SF3B1突变型造血干/祖细胞的髓系转录程序及分化产生相反的调控作用。
- 高危RUNX1和STAG2突变(而非低危TET2突变)可扩增不同的SF3B1突变型造血干/祖细胞亚群。
核心结论
- 从低危向高危MDS的进展依共突变模式涉及不同的分子与细胞路径。
研究设计与样本
- 研究整合了SF3B1突变患者的临床与分子特征分析,并对原代及诱导多能干细胞来源的人造血干/祖细胞进行基因编辑。
主要发现
- 继发性RUNX1或STAG2突变在临床上与疾病进展期和生存期缩短相关。
- RUNX1和STAG2突变对SF3B1突变型造血干/祖细胞的髓系转录程序及分化产生相反的调控作用。
- 高危RUNX1和STAG2突变(而非低危TET2突变)扩增了不同的SF3B1突变型造血干/祖细胞亚群。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myelodysplastic syndromes (MDS) are clonal stem cell disorders driven by heterogeneous genetic alterations leading to variable clinical course. MDS with splicing factor SF3B1 mutations is a distinct subtype with a favorable outcome. However, selected comutations induce poor prognosis and how these genetic lesions cooperate in human hematopoietic stem and progenitor cells (HSPCs) during disease progression is still unclear. Here, we integrated clinical and molecular profiling of patients with SF3B1 mutations with gene editing of primary and induced pluripotent stem cell-derived human HSPCs to show that high-risk comutations impart distinct effects on lineage programs of SF3B1-mutant HSPCs. Secondary RUNX1 or STAG2 mutations were clinically associated with advanced disease and reduced survival. However, RUNX1 and STAG2 mutations induced opposing regulation of myeloid transcriptional programs and differentiation in SF3B1-mutant HSPCs. Moreover, high-risk RUNX1 and STAG2, but not low-risk TET2, mutations expanded distinct SF3B1-mutant HSPC subpopulations. These findings provide evidence that progression from low- to high-risk MDS involves distinct molecular and cellular routes depending on comutation patterns.
引用
- Sarchi M, Clough CA, Gallì A, et al. Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes. Blood Adv. 2025. PMID: 40188457. doi:10.1182/bloodadvances.2024014965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。